AR082132A1 - Derivados de 1,2,4-oxadiazol, composiciones farmaceuticas que los contienen, proceso para prepararlos y uso de los mismos para tratar enfermedades inmunologicas e inflamatorias autoinmunes - Google Patents
Derivados de 1,2,4-oxadiazol, composiciones farmaceuticas que los contienen, proceso para prepararlos y uso de los mismos para tratar enfermedades inmunologicas e inflamatorias autoinmunesInfo
- Publication number
- AR082132A1 AR082132A1 ARP110102449A AR082132A1 AR 082132 A1 AR082132 A1 AR 082132A1 AR P110102449 A ARP110102449 A AR P110102449A AR 082132 A1 AR082132 A1 AR 082132A1
- Authority
- AR
- Argentina
- Prior art keywords
- hal
- derivatives
- represent
- independently
- same
- Prior art date
Links
- BBVIDBNAYOIXOE-UHFFFAOYSA-N 1,2,4-oxadiazole Chemical class C=1N=CON=1 BBVIDBNAYOIXOE-UHFFFAOYSA-N 0.000 title 1
- 230000001900 immune effect Effects 0.000 title 1
- 208000026278 immune system disease Diseases 0.000 title 1
- 208000027866 inflammatory disease Diseases 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 3
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 3
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 abstract 2
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 abstract 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 1
- 229930182480 glucuronide Natural products 0.000 abstract 1
- 150000008134 glucuronides Chemical class 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 150000004866 oxadiazoles Chemical class 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
- 125000000876 trifluoromethoxy group Chemical group FC(F)(F)O* 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
- C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
- C07D271/06—1,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4245—Oxadiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pain & Pain Management (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Dermatology (AREA)
- Heart & Thoracic Surgery (AREA)
- Gastroenterology & Hepatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP10168833 | 2010-07-08 | ||
| US36274610P | 2010-07-09 | 2010-07-09 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR082132A1 true AR082132A1 (es) | 2012-11-14 |
Family
ID=42341535
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP110102449 AR082132A1 (es) | 2010-07-08 | 2011-07-08 | Derivados de 1,2,4-oxadiazol, composiciones farmaceuticas que los contienen, proceso para prepararlos y uso de los mismos para tratar enfermedades inmunologicas e inflamatorias autoinmunes |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US9029405B2 (enExample) |
| EP (1) | EP2590956B1 (enExample) |
| JP (1) | JP6014589B2 (enExample) |
| KR (1) | KR20140003379A (enExample) |
| CN (1) | CN103097365B (enExample) |
| AR (1) | AR082132A1 (enExample) |
| AU (1) | AU2011275854B2 (enExample) |
| CA (1) | CA2804473C (enExample) |
| EA (1) | EA201300092A1 (enExample) |
| ES (1) | ES2586145T3 (enExample) |
| IL (1) | IL224071B (enExample) |
| MX (1) | MX2012015021A (enExample) |
| SG (1) | SG186872A1 (enExample) |
| TW (1) | TW201206429A (enExample) |
| WO (1) | WO2012004287A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102250035A (zh) * | 2011-06-10 | 2011-11-23 | 北京富卡生物技术有限公司 | 二芳基取代-1，3，4-噁二唑化合物的合成方法和其药物用途 |
| CN107857760A (zh) * | 2017-11-21 | 2018-03-30 | 南京天翔医药科技有限公司 | 鞘氨醇‑1‑磷酸受体调节剂及其应用 |
| FI4081511T3 (fi) * | 2019-12-23 | 2024-10-24 | Sitryx Therapeutics Ltd | Karboksijohdannaisia, joilla on anti-inflammatorisia ominaisuuksia |
| EP4126827B1 (en) * | 2020-03-27 | 2024-11-20 | Receptos LLC | Sphingosine 1 phosphate receptor modulators |
| WO2022212769A1 (en) * | 2021-03-31 | 2022-10-06 | Washington University | Compositions for binding sphingosine-1-phosphate receptor 1 (s1p1), imaging of s1p1, and processes for preparation thereof |
| WO2022220608A1 (ko) * | 2021-04-14 | 2022-10-20 | 주식회사 엘지화학 | 스핑고신-1-인산 수용체 효능제 합성을 위한 중간체의 제조방법 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE177439T1 (de) | 1994-11-05 | 1999-03-15 | Basf Ag | Melaminharze |
| CA2547198A1 (en) * | 2003-12-17 | 2005-06-30 | Merck & Co., Inc. | (3,4-disubstituted)propanoic carboxylates as s1p (edg) receptor agonists |
| US20060223866A1 (en) * | 2004-08-13 | 2006-10-05 | Praecis Pharmaceuticals, Inc. | Methods and compositions for modulating sphingosine-1-phosphate (S1P) receptor activity |
| GB0511684D0 (en) * | 2005-06-08 | 2005-07-13 | Novartis Ag | Organic compounds |
| EP1893591A1 (en) | 2005-06-08 | 2008-03-05 | Novartis AG | POLYCYCLIC OXADIAZOLES OR I SOXAZOLES AND THEIR USE AS SlP RECEPTOR LIGANDS |
| TWI404706B (zh) * | 2006-01-11 | 2013-08-11 | Actelion Pharmaceuticals Ltd | 新穎噻吩衍生物 |
| GB0601744D0 (en) * | 2006-01-27 | 2006-03-08 | Novartis Ag | Organic compounds |
| JP2009269819A (ja) * | 2006-08-25 | 2009-11-19 | Asahi Kasei Pharma Kk | アミン化合物 |
| CA2664268A1 (en) * | 2006-09-29 | 2008-04-03 | Novartis Ag | Diaryl oxadiazol derivatives |
| KR20100075608A (ko) * | 2007-10-04 | 2010-07-02 | 메르크 세로노 에스. 에이. | 옥사다이졸 유도체 |
| TW201000099A (en) * | 2008-06-20 | 2010-01-01 | Amgen Inc | S1P1 receptor agonists and use thereof |
| EP2241558A1 (en) * | 2009-04-03 | 2010-10-20 | Merck Serono SA | Oxadiazole derivatives |
-
2011
- 2011-07-01 TW TW100122179A patent/TW201206429A/zh unknown
- 2011-07-06 CA CA2804473A patent/CA2804473C/en not_active Expired - Fee Related
- 2011-07-06 JP JP2013517372A patent/JP6014589B2/ja not_active Expired - Fee Related
- 2011-07-06 EP EP11729318.3A patent/EP2590956B1/en not_active Not-in-force
- 2011-07-06 AU AU2011275854A patent/AU2011275854B2/en not_active Ceased
- 2011-07-06 EA EA201300092A patent/EA201300092A1/ru unknown
- 2011-07-06 WO PCT/EP2011/061372 patent/WO2012004287A1/en not_active Ceased
- 2011-07-06 CN CN201180033823.9A patent/CN103097365B/zh not_active Expired - Fee Related
- 2011-07-06 MX MX2012015021A patent/MX2012015021A/es not_active Application Discontinuation
- 2011-07-06 SG SG2012096533A patent/SG186872A1/en unknown
- 2011-07-06 ES ES11729318.3T patent/ES2586145T3/es active Active
- 2011-07-06 US US13/809,013 patent/US9029405B2/en not_active Expired - Fee Related
- 2011-07-06 KR KR20137003335A patent/KR20140003379A/ko not_active Withdrawn
- 2011-07-08 AR ARP110102449 patent/AR082132A1/es not_active Application Discontinuation
-
2012
- 2012-12-31 IL IL224071A patent/IL224071B/en active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| EA201300092A1 (ru) | 2013-06-28 |
| CA2804473A1 (en) | 2012-01-12 |
| EP2590956B1 (en) | 2016-05-04 |
| JP6014589B2 (ja) | 2016-10-25 |
| EP2590956A1 (en) | 2013-05-15 |
| AU2011275854B2 (en) | 2015-08-27 |
| CN103097365A (zh) | 2013-05-08 |
| CN103097365B (zh) | 2016-02-24 |
| SG186872A1 (en) | 2013-02-28 |
| MX2012015021A (es) | 2013-04-03 |
| WO2012004287A1 (en) | 2012-01-12 |
| AU2011275854A1 (en) | 2013-02-21 |
| US20130116289A1 (en) | 2013-05-09 |
| IL224071B (en) | 2018-06-28 |
| TW201206429A (en) | 2012-02-16 |
| KR20140003379A (ko) | 2014-01-09 |
| CA2804473C (en) | 2019-04-02 |
| US9029405B2 (en) | 2015-05-12 |
| ES2586145T3 (es) | 2016-10-11 |
| JP2013530202A (ja) | 2013-07-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR082132A1 (es) | Derivados de 1,2,4-oxadiazol, composiciones farmaceuticas que los contienen, proceso para prepararlos y uso de los mismos para tratar enfermedades inmunologicas e inflamatorias autoinmunes | |
| AR086958A1 (es) | Antagonistas de trpv4 | |
| AR082768A1 (es) | Derivados de indolizina, su procedimiento de preparacion y composiciones farmaceuticas que los contienen | |
| CO6260062A2 (es) | (carboxilalquilenfenil)feniloxamidas metodo para su produccion y uso de las mismas como medicamentos | |
| PE20130311A1 (es) | Composiciones y metodos para modular la via de senalizacion de wnt | |
| PE20151860A1 (es) | Derivados de 6-(5-hidroxi-1h-pirazol-1-il)nicotinamida y su uso como inhidores de la phd | |
| PE20151794A1 (es) | Compuestos de 1,3-oxazin-2-amina fusionados con ciclopropilo perfluorado como inhibidores de beta-secretasa y metodos de uso | |
| AR082112A1 (es) | Derivados de imidazopiridina, su procedimiento de preparacion y su aplicacion en terapeutica | |
| DOP2014000133A (es) | Triazolopiridinas sustituidas | |
| AR063015A1 (es) | Derivados de quinazolinona 5-sustituida y composiciones que los comprenden y metodos para utilizarlos en el tratamiento del cancer | |
| DOP2010000191A (es) | Derivados bis-(sulfonilamino) | |
| CO6640270A2 (es) | Morfolinopirimidad y su uso en terapia | |
| AR083026A1 (es) | Derivados de ciclohexenona y composiciones para el tratamiento del cancer de pulmon | |
| CO6150159A2 (es) | Compuestos de heteroarilo utiles como inhibidores de enzimas de activacion e1 | |
| AR076435A1 (es) | Compuestos de indazoles sustituidos, composiciones farmaceuticas que los contienen y procesos de obtencion de los mismos | |
| AR084011A1 (es) | Compuestos nitrogenados heterociclicos utiles para el tratamiento de infecciones por el virus sincitial respiratorio (rsv), proceso para prepararlos y composiciones farmaceuticas que los contienen | |
| CR20140294A (es) | Derivados de dihidro-benzo-oxazina y dihidro-pirido-oxazina | |
| AR081638A1 (es) | Amidas c-28 de derivados del acido betulinico c-3 modificados como inhibidores de la maduracion del vih | |
| AR053994A1 (es) | Sulfonilpirrolidinas sustituidas procedimiento para su preparacion y su uso como medicamentos | |
| CO6650348A2 (es) | Triazolopiridinas sustituidas | |
| AR069789A1 (es) | Pirazoles condensados, una composicion farmaceutica que los contiene y su uso en la preparacion de un medicamento para el tratamiento del sida o el arc. | |
| AR083903A1 (es) | Derivados de benzooxazol y benzotiazol sulfonamidas, utiles para tratar trastornos del ritmo cardiaco y cancer, composiciones farmaceuticas que los contienen y metodo para prepararlos | |
| CY1113914T1 (el) | Νεα παραγωγα διυδροϊνδολονων, μεθοδος παρασκευης τους και φαρμακευτικες συνθεσεις οι οποιες τα περιεχουν | |
| SV2012004203A (es) | Nueva asociación entre la 4-{3-[cis-hexahidrociclopenta[c]pirrol-2(1h)-il]propoxi}benzamida y un inhibidor de la acetilcolinesterasa y las composiciones farmacéuticas que la contienen | |
| CO6362013A2 (es) | Derivados de rifamicina |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |